Delivery Order SPE2DB25D9301-SPE2DB25FQTEK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,128.96 to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of IOSAT 130 mg tablets in quantities of 14 units. The contract is firm fixed-price with an ultimate completion date of September 8, 2025, and will be performed in Park Ridge, Illinois. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its status as a woman-owned small...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for IOSAT 130 MG tablets in a 14-count package on September 22, 2025. This firm fixed-price delivery order, valued at $2,822.40, is set to be completed by September 23, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. The award carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small...
- The Defense Logistics Agency awarded a delivery order valued at $1,612.80 to DMS Pharmaceutical Group Inc. for IOSAT 130 mg tablets (14-count packaging) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a routine pharmaceutical supply transaction under DMS Pharmaceutical Group's existing...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract worth $13,708.97 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of IOSAT 130 MG TABLET 14S, with a completion date of February 12, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 under the SPE2DB program, which has a total potential...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,225.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,612.80 by the Defense Logistics Agency on August 12, 2025, for IOSAT 130 mg tablets (14-count package). This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, valued at approximately $500 million and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,016.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price model with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,612.80 by the Defense Logistics Agency on August 15, 2025. The delivery order, which is for Iosatâ„¢ 130 mg tablets (14-count packaging), is scheduled for completion by August 18, 2025, with performance taking place at the contractor's Park Ridge facility. This award was made without a set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $2,016 delivery order by the Defense Logistics Agency on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract calls for the supply of IOSAT 130 mg tablets in quantities of 14, using firm fixed-price pricing with no set-aside designation. The delivery order is performed at the contractor's Park Ridge, Illinois location and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,466.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 27, 2024, is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product. This award is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- SPE2DB25D9301Indefinite Delivery Contract
- SPE2DB25D9301-SPE2DB25FQTEKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,844.17 to DMS Pharmaceutical Group Inc. on March 18, 2025, for the supply of IOSAT 130 mg tablets (14-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of March 19, 2025, and represents a small pharmaceutical supply requirement for federal healthcare operations. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned small business. DMS Pharmaceutical Group Inc., headquartered in Park Ridge, Illinois, is a specialized pharmaceutical wholesaler with extensive experience supplying medical products to Department of Defense healthcare facilities. This delivery order is issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency, a single-award vehicle valued at approximately $500 million and valid through November 2026. Through this IDC arrangement, the Defense Logistics Agency can efficiently procure a comprehensive range of pharmaceutical products, including prescription medications, over-the-counter drugs, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group's consistent track record of federal pharmaceutical supply contracts demonstrates its established position within the defense healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 3/18/25 |